2004.-Accumulating evidence suggests that central thyrotropin-releasing hormone (TRH) administration induces gastric erosion 4 h after administration through the vagal nerves. However, early changes in the gastric mucosa during these 4 h have not been described. To assess early changes in the gastric mucosa after intracisternal injection of a stable TRH analog, pGlu-His-(3,3Ј-dimethyl)-ProNH 2 (RX-77368), we measured the blood-to-lumen 51 Cr-labeled EDTA clearance and examined the effects of vagotomy, atropine, omeprazole, and hydrochloric acid (HCl) on RX-77368-induced mucosal permeability. A cytoprotective dose of RX-77368 (1.5 ng) did not increase mucosal permeability. However, higher doses significantly increased mucosal permeability. Permeability peaked within 20 min and gradually returned to control levels in response to a 15-ng dose (submaximal dose). Increased mucosal permeability was not recovered after a 150-ng dose (ulcerogenic dose). This increase in permeability was inhibited by vagotomy or atropine. Intragastric perfusion with HCl did not change the RX-77368 (15 ng)-induced increase in permeability, but completely inhibited the recovery of permeability after the peak. Pretreatment with omeprazole did not change the RX-77368 (15 ng)-induced increase in permeability, but quickened the recovery of permeability after the peak. These data indicate that the RX-77368-induced increase in permeability is mediated via the vagal-cholinergic pathway and is not a secondary change in RX-77368-induced acid secretion. Inhibited recovery of permeability on exposure to an ulcerogenic RX-77368 dose or on exposure to HCl plus a submaximal dose of RX-77368 may be crucial for the induction of gastric mucosal lesions by central RX-77368 administration. intracisternal injection; 51 Cr-labeled EDTA clearance THE ROLE OF THE CENTRAL NERVOUS SYSTEM in the regulation of gastric function has long been recognized. Thyrotropin-releasing hormone (TRH), a stress-related neuropeptide originally isolated from the hypothalamus (1, 10), or its stable analog pGlu-His-(3,3Ј-dimethyl)-ProNH 2 (RX-77368) has been reported to act in the brain to stimulate gastrointestinal secretion, motility, transit, and ulcer formation in conscious or anesthetized rats, rabbits, and cats (14, 15). Many studies (14,15) indicate that TRH actions on gut function are mediated through activation of the parasympathetic outflow and peripheral muscarinic receptors. TRH or stable TRH analogs injected into the cisterna magna show cytoprotective (19, 25) and ulcerogenic effects (3, 14) on gastric mucosa (17, 18). These stress-related effects on gastric mucosa depend on the balance between vagally activated increases in ulcerogenic agents including acid secretion (16) and cytoprotective factors such as prostaglandins (25) and heat shock proteins (8).Mucosal permeability plays a key role in regulation of gastric integrity. Although the vagal cholinergic-mediated effects of gastric acid secretion or mucosal blood flow on gut function are well characterized in response...